Key result
Malignant processes, such as melanoma, subject the heart to additional loading and potential cardiac muscle damage driven by tumor biology and cardiotoxic treatments.
Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Alerts clinicians to melanoma cardiotoxicity pathways; leaves open targeted prevention trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kit et al. (2022) studied this question. Malignant processes, such as melanoma, subject the heart to additional loading and potential cardiac muscle damage driven by tumor biology and cardiotoxic treatments.
Synapse has enriched 10 related papers. Consider them for comparative context: